Significantly increased threshold dose after long-term peanut epicutaneous immunotherapy and daily oral peanut intake.

导出原文传递

翻译打印收藏纠错

作者： Whitney Reid,Fink ^[1] ; Peter,Capucilli ^[2] ; Megan O,Lewis ^[2] ; Courtney B,Rooney ^[2] ; Terri F,Brown-Whitehorn ^[2]

作者单位： Children's Hospital of Philadelphia, Pennsylvania. Electronic address: Finkw@email.chop.edu. ^[1] Children's Hospital of Philadelphia, Pennsylvania. ^[2]

主题词青少年(Adolescent);脱敏法, 免疫(Desensitization, Immunologic);人类(Humans);男(雄)性(Male);花生过敏(Peanut Hypersensitivity)

DOI 10.1016/j.anai.2020.01.021

PMID 32006703

发布时间 2020-05-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Annals of allergy, asthma & immunology

2020年124卷4期

403-405.e1页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Significantly increased threshold dose after long-term peanut epicutaneous immunotherapy and daily oral peanut intake.

Annals of allergy, asthma & immunology

相似文献

Annals of allergy, asthma & immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Significantly increased threshold dose after long-term peanut epicutaneous immunotherapy and daily oral peanut intake.

Annals of allergy, asthma & immunology

相似文献

Annals of allergy, asthma & immunology

相关期刊

检索历史清除